Phipatanakul W, Vogelberg C, Bacharier LB, Dell S, et al. Dupilumab 200 mg was efficacious in children (6-11 years) with moderate-to-severe asthma for up to 2 years: EXCURSION open-label extension study. Pediatr Pulmonol 2024 Jul 17. doi: 10.1002/ppul.27167.
PMID: 39016623